AdipoGen Life Sciences

Rotenone

CHF 65.00
In stock
AG-CN2-0516-G0011 gCHF 65.00
AG-CN2-0516-G0055 gCHF 150.00
More Information
Product Details
Synonyms Nicouline; NSC 8505; NSC 26258; Tubatoxin
Product Type Chemical
Properties
Formula

C23H22O6

MW 394.4
CAS 83-79-4
RTECS DJ2800000
Source/Host Chemicals Isolated from Fabaceae species.
Purity Chemicals ≥97%
Appearance White to off-white solid.
Solubility Soluble in DMSO (20mg/ml), ethanol (1mg/ml) or chloroform (20mg/ml).
Identity Determined by 1H-NMR.
InChi Key JUVIOZPCNVVQFO-HBGVWJBISA-N
Smiles CC([C@@]1([H])CC2=C(O[C@]3([H])COC4=CC(OC)=C(OC)C=C4[C@]3([H])C5=O)C5=CC=C2O1)=C
Shipping and Handling
Shipping AMBIENT
Short Term Storage +4°C
Long Term Storage -20°C
Handling Advice Keep cool and dry.
Protect from light.
Use/Stability Stable for at least 2 years after receipt when stored at -20°C.
Documents
MSDS Download PDF
Product Specification Sheet
Datasheet Download PDF
Description
  • Cell permeable reversible and competitive mitochondrial electron transport chain complex I (NADH-CoQ reductase) inhibitor (IC50=1.7-2.2μM).
  • Inhibits NADH/DB oxidoreductase and NADH oxidase and consequently oxidative phosphorylation (OXPHOS). Specifically inhibits NAD-linked substrate oxidation of NADH dehydrogenase.
  • Useful agent for immunometabolism research. Inhibition of electron transport chain in mitochondria leads to blocking of the transfer of electrons from iron-sulfur centers in complex I to ubiquinone. This interferes with NADH during the creation of usable cellular energy (ATP), and Complex I is unable to pass off its electron to CoQ, creating a back-up of electrons within the mitochondrial matrix. Cellular oxygen is reduced to the radical, creating reactive oxygen species, which can damage DNA and other components of the mitochondria.
  • Shown to inhibit mammalian cell proliferation, via suppressing microtubule assembly by binding to tubulin and inhibiting autophagy induction, by blocking lysosomal degradation of autophagic vacuoles.
  • Shown to induce cell cycle arrest and apoptosis through production of mitochondrial ROS, consequently leading to induction of oxidative stress.
  • Used to induce Parkinson's diseases-like syndrome in experimental animal model.
  • Selective priming signal for NLRP3 inflammasome activation in combination with ATP, but not with Nigericin or MSU.
  • Commonly used as a broad spectrum insecticide, piscicide and pesticide.
Product References
  1. Rotenone, an anticarcinogen, inhibits cellular proliferation but not peroxisome proliferation in mouse liver: M.L. Cunningham, et al.; Cancer Lett. 95, 93 (1995)
  2. Rotenone-induced G2/M cell cycle arrest and apoptosis in a human B lymphoma cell line PW: J.S. Armstrong, et al.; BBRC 289, 973 (2001)
  3. Mitochondrial complex I inhibitor rotenone induces apoptosis through enhancing mitochondrial reactive oxygen species production: N. Li, et al.; J. Biol. Chem. 278, 8516 (2003)
  4. Rotenone induces cell death in primary dopaminergic culture by increasing ROS production and inhibiting mitochondrial respiration: K. Radad, et al.; Neurochem. Int. 49, 379 (2006)
  5. Rotenone inhibits mammalian cell proliferation by inhibiting microtubule assembly through tubulin binding: P. Srivastava & D. Panda; FEBS J. 274, 4788 (2007)
  6. Pesticides and impairment of mitochondrial function in relation with the parkinsonian syndrome: C. Gomez, et al.; Front. Biosci. 12, 1079 (2007)
  7. Mechanisms of rotenone-induced proteasome inhibition: A.P. Chou, et al.; Neurotoxicol. 31, 367 (2010)
  8. Rotenone inhibits autophagic flux prior to inducing cell death: B.J. Mader, et al.; ACS Chem. Neurosci. 3, 1063 (2012)
  9. Mitochondrial complex I inhibitor rotenone-induced toxicity and its potential mechanisms in Parkinson's disease models: N. Xiong, et al.; Crit. Rev. Toxicol. 42, 613 (2012) (Review)
  10. Rotenone-induced oxidative stress and apoptosis in human liver HepG2 cells: M.A. Siddiqui, et al.; Mol. Cell Biochem. 384, 59 (2013)
  11. The rotenone model of Parkinson's disease: genes, environment and mitochondria: J.T. Greenamyre, et al.; Parkinsonism Relat. Disord. 9, S59 (2013) (Review)
  12. Metabolome and proteome profiling of complex I deficiency induced by rotenone: I. Gielisch, & D. Meierhofer ; J. Proteome Res. 14, 224 (2015)
  13. Rotenone-induced Impairment of Mitochondrial Electron Transport Chain Confers a Selective Priming Signal for NLRP3 Inflammasome Activation: J.H. Won, et al.; J. Biol. Chem. 290, 27425 (2015)
  14. Succinate Dehydrogenase Supports Metabolic Repurposing of Mitochondria to Drive Inflammatory Macrophages: E.L. Mills, et al.; Cell 167, 457 (2016)
  15. A guide to immunometabolism for immunologists: L.A. O'Neill, et al.; Nat. Rev. Immunol. 16, 553 (2016)
  16. The respiratory chain inhibitor rotenone affects peroxisomal dynamics via its microtubule-destabilising activity: J.B. Passmore, et al.; Histochem. Cell Biol. 148, 331 (2017)
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.